Incidence and factors associated with cutaneous immune-related adverse events to immune check point inhibitors: An ambispective cohort study

BACKGROUND: Although immune checkpoint inhibitors (ICIs) have become the frontline treatment option for patients with various advanced cancers due to improved survival, they can be associated with a spectrum of cutaneous immune-related adverse events (cirAEs). However, little is known regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales: Luangnara, Athitaya, Kiratikanon, Salin, Ketpueak, Thanika, Suksombooncharoen, Thatthan, Charoentum, Chaiyut, Chewaskulyong, Busyamas, Tovanabutra, Napatra, Chiewchanvit, Siri, Nochaiwong, Surapon, Chuamanochan, Mati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630333/
https://www.ncbi.nlm.nih.gov/pubmed/36341419
http://dx.doi.org/10.3389/fimmu.2022.965550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630333/
https://www.ncbi.nlm.nih.gov/pubmed/36341419
http://dx.doi.org/10.3389/fimmu.2022.965550

Ejemplares similares